September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...
September 18, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for ...
September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 15, 2023 — Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a ...
September 15, 2023 — The American College of Cardiology (ACC) has recognized five Hackensack Meridian Health hospitals ...
September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...
September 14, 2023 — BIOTRONIK announced the two-year-results from the BIOLUX P-III BENELUX all-comers registry ...
September 14, 2023 — Myocardial infarction, the number one cause of sudden death in adults and the number two cause of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...
September 13, 2023 — Socioeconomic status (education, income, employment status and health insurance) appears to be an ...
September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...
September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...
September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...